Immunosuppressive Agents: all 5,940 studies that test it
Page 58 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorCompletedNCT00006358Phase 2
- Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00006350Phase 2
- Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or LymphomaCompletedNCT00006252Phase 2
- Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerCompletedNCT00006251Phase 1/2
- Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV MelanomaCompletedNCT00006233Phase 2
- Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00006226Phase 2
- Thalidomide and Dacarbazine for Metastatic MelanomaStatus unknownNCT00006200Phase 2
- Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular CancerStatus unknownNCT00006198Phase 2
- Ursodiol-Methotrexate for Primary Biliary CirrhosisCompletedNCT00006168Phase 3
- Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar ExtractionCompletedNCT00006070Phase 2
- Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00006042Phase 1
- Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck CancerCompletedNCT00006033Phase 2
- Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT00006016Phase 2
- Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically RemovedCompletedNCT00006006Phase 2
- Thalidomide in Treating Patients With Gynecologic SarcomasCompletedNCT00006005Phase 2
- Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyCompletedNCT00005988Phase 1
- Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous LeukemiaTerminatedNCT00005986Phase 2
- Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous LeukemiaTerminatedNCT00005984Phase 2
- Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic LeukemiaCompletedNCT00005977Phase 3
- Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerCompletedNCT00005970Phase 3
- Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00005966Phase 3
- Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00005964Phase 2
- Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00005960Phase 2
- Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005945Phase 3
- Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal CancerCompletedNCT00005941Phase 2
- Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First RemissionCompletedNCT00005940Phase 2
- Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic AnemiaCompletedNCT00005935Phase 2
- Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's AnemiaCompletedNCT00005898Phase 1/2
- Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's AnemiaCompletedNCT00005892Not applicable
- Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's AnemiaCompletedNCT00005891Not applicable
- S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid LeukemiaCompletedNCT00005866Phase 3
- Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney CancerCompletedNCT00005851Phase 1/2
- S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple MyelomaTerminatedNCT00005834Phase 3
- Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00005815Phase 1/2
- Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005804Phase 2
- Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00005799Not applicable
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast CancerCompletedNCT00005798Phase 2
- Bone Marrow Transplant in Treating Patients With Hematologic CancersCompletedNCT00005797Phase 2
- Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersCompletedNCT00005622Phase 2
- Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00005613Phase 2
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00005596Phase 3
- Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic SyndromeCompletedNCT00005593Phase 1
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005585Phase 3
- Combination Chemotherapy in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00005581Phase 3
- Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaCompletedNCT00005580Phase 1
- A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney TransplantTerminatedNCT00005113Phase 3
- Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005092Phase 1
- S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's DiseaseTerminatedNCT00005090Phase 3
- Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder CancerCompletedNCT00005086Phase 2
- Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant DiseaseStatus unknownNCT00005024Phase 3
- Etanercept for Wegener's GranulomatosisCompletedNCT00005007Phase 2/3
- Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00004908Phase 2
- Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT00004898Phase 1/2
- Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00004896Phase 2
- Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial CancerCompletedNCT00004876Phase 2
- Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00004862Phase 1
- Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00004857Phase 2
- Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary CirrhosisCompletedNCT00004784Phase 3
- Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing CholangitisCompletedNCT00004762Phase 2
- Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary CirrhosisCompletedNCT00004748Phase 3
- Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsCompletedNCT00004688Phase 2
- Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell ArteritisCompletedNCT00004686Phase 2
- Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell MyocarditisCompletedNCT00004482Phase 2
- Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic AnemiaCompletedNCT00004474Phase 3
- Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal HemoglobinuriaCompletedNCT00004464Phase 2
- Randomized Study of Beta Interferon and Thalidomide in Patients With AdrenoleukodystrophyCompletedNCT00004450Not applicable
- Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV InfectionsCompletedNCT00004276Phase 2
- Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or LarynxCompletedNCT00004246Phase 1
- Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast CancerCompletedNCT00004237Phase 2
- Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic LeukemiaCompletedNCT00004218Phase 3
- Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic SyndromeCompletedNCT00004208Phase 3
- Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host DiseaseStatus unknownNCT00004194Phase 1/2
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast CancerCompletedNCT00004175Phase 2
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerCompletedNCT00004174Phase 1
- Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's LymphomaCompletedNCT00004162Phase 1
- Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004145Phase 2
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerCompletedNCT00004135Phase 2
- Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph NodesCompletedNCT00004125Phase 3
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaCompletedNCT00004112Phase 3
- Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate CancerCompletedNCT00004071Phase 2/3
- Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's DiseaseCompletedNCT00004010Phase 2
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast CancerCompletedNCT00003972Phase 3
- Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast CancerCompletedNCT00003927Phase 1
- Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast CancerStatus unknownNCT00003920Phase 1
- Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow TransplantCompletedNCT00003894Phase 2
- Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic LeukemiaCompletedNCT00003870Phase 2
- Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid LeukemiaCompletedNCT00003868Phase 2
- Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNSCompletedNCT00003859Phase 3
- Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00003850Phase 2
- Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal TumorsCompletedNCT00003846Phase 2
- Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00003829Phase 2
- Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic LeukemiaCompletedNCT00003783Phase 2
- Leflunomide in Treating Patients With Anaplastic Astrocytoma in First RelapseCompletedNCT00003775Phase 2
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00003764Phase 3
- Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood CancersCompletedNCT00003754Phase 2
- Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic LeukemiaTerminatedNCT00003729Phase 2
- Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00003700Phase 2
- Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung CancerStatus unknownNCT00003696Phase 3
- Combination Chemotherapy in Treating Women With Breast CancerStatus unknownNCT00003679Phase 3
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic LeukemiaCompletedNCT00003671Phase 2